Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00552734 · ClinicalTrials.gov registry record

Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software

A clinical trial, sponsored by University of Colorado, Denver.

Completed
Registry status
123
Enrollment target

NCT00552734 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 123 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00552734 has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
123 participants
Enrollment target

Study Summary

140 subjects will be enrolled into the clinical study and randomized into the Control Group or the Experimental Group by block randomization. The subjects must meet all inclusion and none of the exclusion criteria. Each subject will have 7 clinic visits and 3 phone visits. The Baseline Visit will consist of a complete history, vitals, a physical examination and completion of the consent and screening process. All clinic visits, except for the Baseline Visit will include meter/PDA download. In addition, meter education will be provided to all subjects, and PDA education will be provided to the Experimental group at the Baseline Visit and 2-Week Visit as needed to ensure subject understanding. The phone visits will consist of a history including any changes in insulin dose, and any hypoglycemic events, hyperglycemic events, or other adverse events that have occurred since the last clinic visit. The primary endpoint in this study was to show a reduction in A1c of at least 0.4% or higher in the insulin guidance software group at 6 months and/or 1 year.

Interventions

  • DEVICE Insulin Guidance Software

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2005-07
Est. Completion 2007-05

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00552734

The ClinicalTrials.gov registry entry for NCT00552734 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Insulin Guidance Software is the first listed.

NCT00552734 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00552734 about?

NCT00552734 is a clinical study titled "Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software". 140 subjects will be enrolled into the clinical study and randomized into the Control Group or the Experimental Group by block randomization. The subjects must meet all inclusion and none of the exclusion criteria. Each subject will have 7 clinic visits and 3 phone visits. The Baseline Visit will co...

What is the current status of trial NCT00552734?

This trial is currently completed. The enrollment target is 123 participants. The study started on 2005-07. Estimated completion is 2007-05.

What interventions are being tested in trial NCT00552734?

The interventions under investigation include: Insulin Guidance Software (DEVICE).

Who is sponsoring clinical trial NCT00552734?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.